Matthew T. Wiley is CHIEF COMMERCIAL OFFICER of BioXcel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BioXcel Therapeutics, Inc.
16 Mar 23
4
BioXcel Therapeutics, Inc.
19 Jan 22
3
BioXcel Therapeutics, Inc.
19 Jan 22
4
VYNE Therapeutics Inc.
2 Jul 21
4
VYNE Therapeutics Inc.
2 Apr 21
4
VYNE Therapeutics Inc.
24 Feb 21
4
VYNE Therapeutics Inc.
5 Jan 21
4
VYNE Therapeutics Inc.
2 Dec 20
4
VYNE Therapeutics Inc.
2 Oct 20
4
Menlo Therapeutics Inc.
2 Jul 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Mar 23 | BTAI BioXcel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 19.6 | 36,000 | 705.60 k | 36,000 |
| 15 Mar 23 | BTAI BioXcel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 12,000 | 0.00 | 12,000 |
| 17 Jan 22 | BTAI BioXcel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 19.5 | 85,000 | 1.66 mm | 85,000 |